As shown in Fig. 9, Wogonin suppressed the activity of Nrf2/ARE pathway in resistant CML cells at posttranscriptional regulation via NF-κB inactivation. The gene discussed is NFE2L2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.